With only one company set to list this month, it appears that the volatility that surrounds the ASX is prompting some companies to delay listing until some degree of normality in financial markets is restored. One company brave enough to face the current environment is Atomo Diagnostics Limited (Proposed ASX: AT1). The Sydney-based medical diagnostics
Read More
Where to look for dividends in the current market downturn With our stock market losing plenty of value, the historical dividends are suggesting that many stocks are trading at a very attractive dividend yield. However, this may be a value trap on many stocks, who are unlikely to maintain the same dividends that they paid
Read More
As the world battles the coronavirus pandemic, G Medical (ASX: GMV) has secured authorisation from the Food and Drug Administration to sell their Prizma smartphone attachment direct to customers without the need for a prescription, rocketing the company’s share price. Prizma, a smartphone attachment which can monitor a user’s vital signs, can play a vital
Read More
Having been a euphemism for skiving off or perhaps minding sick kids, ‘working from home’ (WFH) has become not just accepted but a compulsory requirement – or imposition – for white collar workers. Our tip is that, post COVID-19, divorce lawyers will emerge as the premier growth sector as working spouses see far too much
Read More
As an industry which had already been fighting for survival before the coronavirus pandemic, the stark reality is that the retail sector will never recover from the fallout of COVID-19. Walking through the corridors of Highpoint Shopping Centre during normal trading hours, more than 80% of retail stores had shut their doors, the only ones
Read More
Prior to COVID-19 bringing attention to the value of telehealth, HeraMED (ASX: HMD) has been building digital infrastructure to revolutionise the maternal healthcare market with their screening and remote midwife platform which is preparing to now enter the lucrative U.S market. The expansion into the world’s most lucrative healthcare market, valued at USD $111 billion
Read More
